Strong Market Position Polfa Tarchomin S.A. is a long-standing leader in anti-infectives with significant market share in insulin, psychotropic drugs, and dermatological products, presenting multiple entry points for urgent care and chronic therapy opportunities.

Extensive Product Portfolio Over a hundred medicinal products across diverse dosage forms and sizes, including gels, aerosols, tablets, capsules, injectables, and insulin cartridges, enabling cross-sell and bundle opportunities across hospital and retail channels.

GMP Certified Capacity Forty production lines and facilities meeting strict global quality standards (GMP) position the company for scaled manufacturing partnerships, contract manufacturing, and private-label opportunities.

Manufacturing Capabilities Specialization in oral penicillin forms, aerosol filling, and freeze-drying techniques highlights potential for collaboration on sterile, high-demand products and accelerated time-to-market for new formulations.

Revenue Growth Case Current revenue range indicates a mid-sized operation with room for volume-based partnerships, regional expansion, and strategic alliances to scale distribution and penetrate new markets in collaborations with larger players.